Yat Sun Or
2021
Compensation breakdown
| Non-Equity Incentive Plan | $224,010 |
|---|---|
| Option Awards | $652,535 |
| Salary | $486,525 |
| Stock Awards | $609,830 |
| Other | $19,211 |
| Total | $1,992,111 |
Or received $652.5K in option awards, accounting for 33% of the total pay in 2021.
Or also received $224K in non-equity incentive plan, $486.5K in salary, $609.8K in stock awards and $19.2K in other compensation.
Rankings
In 2021, Yat Sun Or's compensation ranked 6,064th out of 12,415 executives tracked by ExecPay. In other words, Or earned more than 51.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,064 out of 12,415 | 51st |
Division Manufacturing | 2,563 out of 5,508 | 54th |
Major group Chemicals And Allied Products | 1,121 out of 2,378 | 53rd |
Industry group Drugs | 999 out of 2,099 | 52nd |
Industry Pharmaceutical Preparations | 721 out of 1,549 | 54th |
Pay ratio
| Yat Sun Or's Pay | $1,992,111 |
|---|---|
| Median Employee's Pay | $230,731 |
| Pay Ratio | 9to 1 |
In 2021, the annual total compensation of Yat Sun Or was $1,992,111.
The annual total compensation of the median employee at Enanta Pharmaceuticals was $230,731.
The ratio of Yat Sun Or's pay to the pay of median employee was therefore 9 to one.
Or's colleagues
We found five more compensation records of executives who worked with Yat Sun Or at Enanta Pharmaceuticals in 2021.
2021
Jay Luly
Enanta Pharmaceuticals
Chief Executive Officer
2021
Brendan Luu
Enanta Pharmaceuticals
Senior Vice President, Business Development
2021
Tara Kieffer
Enanta Pharmaceuticals
Senior Vice President, New Product Strategy & Development
2021
Nathaniel Gardiner
Enanta Pharmaceuticals
General Counsel
2021
Paul Mellett
Enanta Pharmaceuticals
Chief Financial Officer
News
January 20, 2023
January 21, 2022
January 21, 2021
January 17, 2020
January 18, 2019